388 related articles for article (PubMed ID: 29221792)
61. Pharmacodynamic effects of serotonin (5-HT) receptor ligands in pigs: stimulation of 5-HT2 receptors induces malignant hyperthermia.
Löscher W; Witte U; Fredow G; Ganter M; Bickhardt K
Naunyn Schmiedebergs Arch Pharmacol; 1990 Jun; 341(6):483-93. PubMed ID: 2118235
[TBL] [Abstract][Full Text] [Related]
62. Potentiation of neurite outgrowth by brexpiprazole, a novel serotonin-dopamine activity modulator: a role for serotonin 5-HT1A and 5-HT2A receptors.
Ishima T; Futamura T; Ohgi Y; Yoshimi N; Kikuchi T; Hashimoto K
Eur Neuropsychopharmacol; 2015 Apr; 25(4):505-11. PubMed ID: 25687838
[TBL] [Abstract][Full Text] [Related]
63. Atypical, but Not Typical, Antipsychotic Drugs Reduce Hypersynchronized Prefrontal-Hippocampal Circuits during Psychosis-Like States in Mice: Contribution of 5-HT2A and 5-HT1A Receptors.
Delgado-Sallent C; Nebot P; Gener T; Fath AB; Timplalexi M; Puig MV
Cereb Cortex; 2022 Aug; 32(16):3472-3487. PubMed ID: 34875009
[TBL] [Abstract][Full Text] [Related]
64. The antipsychotic drug brexpiprazole reverses phencyclidine-induced disruptions of thalamocortical networks.
van den Munkhof HE; Arnt J; Celada P; Artigas F
Eur Neuropsychopharmacol; 2017 Dec; 27(12):1248-1257. PubMed ID: 29128144
[TBL] [Abstract][Full Text] [Related]
65. Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex.
Dawson LA; Nguyen HQ; Smith DL; Schechter LE
J Psychopharmacol; 2002 Jun; 16(2):145-52. PubMed ID: 12095073
[TBL] [Abstract][Full Text] [Related]
66. Interactive effects of mGlu5 and 5-HT2A receptors on locomotor activity in mice.
Halberstadt AL; Lehmann-Masten VD; Geyer MA; Powell SB
Psychopharmacology (Berl); 2011 May; 215(1):81-92. PubMed ID: 21153406
[TBL] [Abstract][Full Text] [Related]
67. Intrathecal 5-methoxy-N,N-dimethyltryptamine in mice modulates 5-HT1 and 5-HT3 receptors.
Alhaider AA; Hamon M; Wilcox GL
Eur J Pharmacol; 1993 Nov; 249(2):151-60. PubMed ID: 7507056
[TBL] [Abstract][Full Text] [Related]
68. 5-HT1A and 5-HT2A receptor control of a panic-like defensive response in the rat dorsomedial hypothalamic nucleus.
de Bortoli VC; Yamashita PS; Zangrossi H
J Psychopharmacol; 2013 Dec; 27(12):1116-23. PubMed ID: 23787365
[TBL] [Abstract][Full Text] [Related]
69. Changes in 5-HT2A-mediated behavior and 5-HT2A- and 5-HT1A receptor binding and expression in conditional brain-derived neurotrophic factor knock-out mice.
Klein AB; Santini MA; Aznar S; Knudsen GM; Rios M
Neuroscience; 2010 Sep; 169(3):1007-16. PubMed ID: 20576498
[TBL] [Abstract][Full Text] [Related]
70. Expression of serotonin 1A and 2A receptors in molecular- and projection-defined neurons of the mouse insular cortex.
Ju A; Fernandez-Arroyo B; Wu Y; Jacky D; Beyeler A
Mol Brain; 2020 Jun; 13(1):99. PubMed ID: 32594910
[TBL] [Abstract][Full Text] [Related]
71. Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs.
Klein LM; Cozzi NV; Daley PF; Brandt SD; Halberstadt AL
Neuropharmacology; 2018 Nov; 142():231-239. PubMed ID: 29499272
[TBL] [Abstract][Full Text] [Related]
72. Serotonergic hallucinogens differentially modify gamma and high frequency oscillations in the rat nucleus accumbens.
Goda SA; Piasecka J; Olszewski M; Kasicki S; Hunt MJ
Psychopharmacology (Berl); 2013 Jul; 228(2):271-82. PubMed ID: 23525524
[TBL] [Abstract][Full Text] [Related]
73. Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans.
Valle M; Maqueda AE; Rabella M; Rodríguez-Pujadas A; Antonijoan RM; Romero S; Alonso JF; Mañanas MÀ; Barker S; Friedlander P; Feilding A; Riba J
Eur Neuropsychopharmacol; 2016 Jul; 26(7):1161-75. PubMed ID: 27039035
[TBL] [Abstract][Full Text] [Related]
74. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
[TBL] [Abstract][Full Text] [Related]
75. Serotonin modulates fast-spiking interneuron and synchronous activity in the rat prefrontal cortex through 5-HT1A and 5-HT2A receptors.
Puig MV; Watakabe A; Ushimaru M; Yamamori T; Kawaguchi Y
J Neurosci; 2010 Feb; 30(6):2211-22. PubMed ID: 20147548
[TBL] [Abstract][Full Text] [Related]
76. Effect of glial cell line-derived neurotrophic factor on behavior and key members of the brain serotonin system in mouse strains genetically predisposed to behavioral disorders.
Naumenko VS; Bazovkina DV; Semenova AA; Tsybko AS; Il'chibaeva TV; Kondaurova EM; Popova NK
J Neurosci Res; 2013 Dec; 91(12):1628-38. PubMed ID: 24105724
[TBL] [Abstract][Full Text] [Related]
77. Abuse liability profile of three substituted tryptamines.
Gatch MB; Forster MJ; Janowsky A; Eshleman AJ
J Pharmacol Exp Ther; 2011 Jul; 338(1):280-9. PubMed ID: 21474568
[TBL] [Abstract][Full Text] [Related]
78. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
[TBL] [Abstract][Full Text] [Related]
79. Aripiprazole inhibits marble-burying behavior via 5-hydroxytryptamine (5-HT)1A receptor-independent mechanisms.
Egashira N; Okuno R; Matsushita M; Abe M; Mishima K; Iwasaki K; Nishimura R; Oishi R; Fujiwara M
Eur J Pharmacol; 2008 Sep; 592(1-3):103-8. PubMed ID: 18644366
[TBL] [Abstract][Full Text] [Related]
80. Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor.
Preller KH; Burt JB; Ji JL; Schleifer CH; Adkinson BD; Stämpfli P; Seifritz E; Repovs G; Krystal JH; Murray JD; Vollenweider FX; Anticevic A
Elife; 2018 Oct; 7():. PubMed ID: 30355445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
